GO:0004772 sterol O-acyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004772 (sterol O-acyltransferase activity) catalyzes the transfer of a long-chain fatty acyl group from acyl-CoA to a sterol, producing a sterol ester and CoA.
• The reaction is carried out by SOAT1 and SOAT2 (also known as ACAT1 and ACAT2), which are endoplasmic reticulum membrane proteins that esterify cholesterol and other sterols [1,2].
• SOAT activity is required for the formation of cholesterol crystals in hepatocyte lipid droplets, linking the enzyme to lipid droplet biology and cholesterol homeostasis.
• SOAT1 acts as a genetic modifier of Niemann-Pick disease, type C1, and SOAT2 contributes to yolk cholesterol trafficking during zebrafish embryogenesis [2,5].
• Selective SOAT2 inhibitors show anti-atherogenic activity in apolipoprotein E knockout mice, and increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity [4,8].
• Studying SOAT function benefits from CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with lipidomics, imaging, and biochemical assays [1,2,4].
Description
Sterol O-acyltransferase activity (GO:0004772) is a molecular function that catalyzes the esterification of sterols using long-chain fatty acyl-CoA substrates, yielding sterol esters and free coenzyme A. This activity is central to cellular cholesterol and sterol homeostasis because esterified sterols are stored in lipid droplets and can be mobilized when free sterol is needed. In mammals, the reaction is primarily mediated by two endoplasmic reticulum enzymes, SOAT1 and SOAT2, which differ in tissue distribution, substrate preference, and physiological roles [1,2]. The importance of this activity extends beyond basic lipid metabolism: it influences membrane organization, lipoprotein assembly, and the formation of cholesterol crystals in hepatocytes. Genetic and pharmacological studies have linked SOAT function to Niemann-Pick disease type C1, atherosclerosis, and anti-tumor immunity, making it a compelling target for both mechanistic and translational research [2,4,8]. Researchers studying sterol O-acyltransferase activity need reliable models to dissect the contributions of SOAT1 versus SOAT2, to test selective inhibitors, and to measure flux through the esterification pathway [3,4]. This article summarizes the definition, mechanism, key genes, disease relevance, and experimental approaches for GO:0004772, with all factual claims supported by the verified literature listed below.
sterol O-acyltransferase activity At A Glance
| GO ID | GO:0004772 |
|---|---|
| GO term | sterol O-acyltransferase activity |
| Ontology | molecular_function |
| Synonym | sterol-ester synthase activity; sterol-ester synthetase activity |
| Major function | Catalysis of the reaction: a long-chain fatty acyl-CoA + a sterol = a sterol ester + CoA |
| Representative enzymes | SOAT1 (ACAT1) and SOAT2 (ACAT2) in mammals; DGAT2-like enzymes in some microorganisms |
| Subcellular location | Endoplasmic reticulum membrane, often associated with lipid droplets |
| Key substrates | Long-chain fatty acyl-CoA and sterols such as cholesterol |
| Key products | Sterol esters and coenzyme A |
What Is GO:0004772?
In simple terms, sterol O-acyltransferase activity is the enzyme function that attaches a fatty acid to a sterol molecule, converting free sterol into a sterol ester. According to the QuickGO definition, it catalyzes the reaction: a long-chain fatty acyl-CoA + a sterol = a sterol ester + CoA. This activity belongs to the molecular_function ontology under GO:0004772 and is also known as sterol-ester synthase activity or sterol-ester synthetase activity. The reaction consumes acyl-CoA and produces a neutral lipid ester that can be stored in lipid droplets, thereby regulating the amount of free sterol available for membrane and signaling functions.
Why Is sterol O-acyltransferase activity Important in Cell Biology?
Sterol O-acyltransferase activity is important because it controls the balance between free sterols and stored sterol esters, a balance that affects membrane fluidity, lipid droplet formation, lipoprotein metabolism, and cellular stress responses. Dysregulation of this activity has been implicated in cholesterol crystal formation in hepatocytes, Niemann-Pick disease type C1, atherosclerosis, and anti-tumor immunity, making it relevant to both rare genetic disorders and common metabolic diseases [1,2,4,8]. Pharmacological inhibitors of SOAT enzymes are used as tools to probe these pathways and have shown anti-atherogenic effects in animal models [3,4]. In addition, sterol O-acyltransferase activity is conserved across eukaryotes and has been studied in non-mammalian systems such as zebrafish and thraustochytrids, where it contributes to yolk cholesterol trafficking and sterol production [5,7].
• Required for the formation of cholesterol crystals in hepatocyte lipid droplets, a process linked to liver lipid stress.
• SOAT1 acts as a genetic modifier of Niemann-Pick disease, type C1, connecting the activity to lysosomal cholesterol trafficking disorders.
• Selective SOAT2 inhibition reduces atherosclerosis in apolipoprotein E knockout mice, supporting the enzyme as a therapeutic target.
• SOAT2 contributes to yolk cholesterol trafficking during zebrafish embryogenesis, highlighting developmental roles.
• Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity.
• The activity is a target of natural product inhibitors such as terpendole congeners and beauveriolide derivatives [3,4].
• It provides a biochemical node for studying lipid droplet biology and neutral lipid storage.
• Conserved in thraustochytrids, where modification of a DGAT2-like enzyme increases sterol production.
• Relevant to lipid-lowering drug research and cholesterol management strategies.
• Enables functional dissection of SOAT1 versus SOAT2 using selective inhibitors and genetic models [3,4].
Molecular Mechanism of sterol O-acyltransferase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs a fatty acid carrier and a sterol molecule.
Sterol O-acyltransferase enzymes bind long-chain fatty acyl-CoA and a sterol substrate, positioning them for catalysis. The reaction consumes acyl-CoA and a sterol and produces a sterol ester plus CoA. In mammals, SOAT1 and SOAT2 differ in their substrate preferences and tissue expression, which influences which sterols are esterified in a given cell type [1,2].
Catalytic transfer of the acyl group
In simple terms: The fatty acid is handed from CoA to the sterol, forming a sterol ester.
The catalytic step transfers the acyl group from acyl-CoA to the hydroxyl group of the sterol, generating a sterol ester and releasing coenzyme A. This esterification converts free sterol into a neutral lipid that can be stored in lipid droplets. The activity is required for cholesterol crystal formation in hepatocyte lipid droplets, indicating that the product sterol esters can seed or support crystal formation under certain conditions.
Product partitioning into lipid droplets
In simple terms: The newly made sterol ester is stored in fat droplets inside the cell.
Sterol esters produced by SOAT activity are hydrophobic and partition into lipid droplets, where they are stored as neutral lipids. This partitioning reduces the amount of free sterol in membranes and influences lipid droplet composition and size. In hepatocytes, SOAT activity is required for the formation of cholesterol crystals within lipid droplets, linking the enzymatic reaction to structural changes in lipid storage organelles.
Regulation by sterol availability and enzyme levels
In simple terms: The enzyme's activity depends on how much sterol and enzyme are present.
Sterol O-acyltransferase activity is influenced by the availability of sterol substrates and by the expression levels of SOAT1 and SOAT2. SOAT1 is widely expressed and can act on various sterols, whereas SOAT2 is more restricted and contributes to specific processes such as yolk cholesterol trafficking in zebrafish and cholesterol metabolism in aged regulatory T cells [5,8]. Selective inhibitors such as beauveriolide derivative BVD327 can discriminate between SOAT2 and SOAT1, showing that the two enzymes have distinct functional roles.
Inhibition and pharmacological modulation
In simple terms: Drugs can block this enzyme, changing how cells store cholesterol.
Natural products and synthetic compounds inhibit sterol O-acyltransferase activity. Terpendole congeners produced by Volutella citrinella BF-0440 are inhibitors of sterol O-acyltransferase. The SOAT2-selective inhibitor BVD327 shows anti-atherogenic activity in apolipoprotein E knockout mice, demonstrating that pharmacological modulation of this activity can affect disease outcomes. These inhibitors are useful tools for dissecting the contributions of SOAT1 and SOAT2 to cellular lipid metabolism [3,4].
Key Genes Involved in GO:0004772 sterol O-acyltransferase activity
The following genes and proteins are directly associated with sterol O-acyltransferase activity or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOAT1 | Major sterol O-acyltransferase in many tissues; esterifies cholesterol and other sterols | Genetic modifier of Niemann-Pick disease type C1; target for functional studies |
| SOAT2 | Sterol O-acyltransferase with restricted expression; contributes to cholesterol trafficking | Selective inhibition reduces atherosclerosis in ApoE knockout mice; linked to anti-tumor immunity in aged Tregs [4,8] |
| ACAT1 | Alternative name for SOAT1; catalyzes sterol esterification | Used interchangeably in literature; relevant to cholesterol crystal formation |
| ACAT2 | Alternative name for SOAT2; catalyzes sterol esterification | Target of selective inhibitors; involved in yolk cholesterol trafficking [4,5] |
| DGAT2-like enzyme (thraustochytrid) | Modification increases sterol production in Aurantiochytrium limacinum | Biotechnological application for sterol production |
| SOAT (zebrafish) | Contributes to yolk cholesterol trafficking during embryogenesis | Developmental model for sterol esterification |
| SOAT1/2 (hepatocyte) | Required for cholesterol crystal formation in lipid droplets | Model for liver lipid droplet biology |
| SOAT2 (regulatory T cells) | Increased expression in aged Tregs alters cholesterol metabolism | Link to anti-tumor immunity |
| Terpendole-sensitive SOAT | Inhibited by terpendole congeners | Natural product inhibitor studies |
| BVD327-sensitive SOAT2 | Selectively inhibited by beauveriolide derivative | Anti-atherogenic drug development |
| SOAT (Niemann-Pick NPC1) | Modifies disease severity in NPC1 | Genetic modifier study |
| SOAT (ApoE knockout mouse) | Target for anti-atherogenic intervention | Preclinical atherosclerosis model |
| SOAT (lipid-lowering drugs) | Related to cholesterol-lowering pharmacology | Review context |
| SOAT (hepatocyte lipid droplet) | Forms cholesterol crystals | Cell biology of lipid storage |
| SOAT (zebrafish embryo) | Yolk cholesterol trafficking | Embryogenesis model |
| SOAT (aged Treg) | Altered cholesterol metabolism | Immunometabolism |
How Is sterol O-acyltransferase activity Regulated?
Sterol O-acyltransferase activity is regulated at multiple levels. Substrate availability, particularly free sterol and acyl-CoA levels, directly influences the reaction rate. The expression of SOAT1 and SOAT2 is tissue-specific and can change with age or disease state; for example, SOAT2 expression is increased in aged regulatory T cells and is associated with altered cholesterol metabolism and reduced anti-tumor immunity. Pharmacological inhibitors can acutely modulate activity, as shown by terpendole congeners and the SOAT2-selective inhibitor BVD327 [3,4]. In addition, genetic variation in SOAT1 can modify the severity of Niemann-Pick disease type C1, indicating that inherited factors influence the activity's impact on disease.
sterol O-acyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOAT1 | Niemann-Pick disease, type C1 (genetic modifier) | Patient-derived cells or NPC1 mutant models with SOAT1 knockout/knockdown |
| SOAT2 | Atherosclerosis (anti-atherogenic effect of inhibition) | ApoE knockout mice treated with SOAT2-selective inhibitor BVD327 |
| SOAT2 | Reduced anti-tumor immunity in aged regulatory T cells | Aged Treg cell models with SOAT2 overexpression or knockout |
| SOAT1/2 | Cholesterol crystal formation in hepatocyte lipid droplets | Hepatocyte cell lines with SOAT knockout and lipid droplet imaging |
| SOAT (zebrafish) | Yolk cholesterol trafficking during embryogenesis | Zebrafish embryos with soat2 knockdown or knockout |
Niemann-Pick disease type C1
SOAT1 has been identified as a genetic modifier of Niemann-Pick disease, type C1, a lysosomal storage disorder characterized by impaired cholesterol trafficking. This suggests that sterol O-acyltransferase activity influences the severity of the disease, possibly by altering the esterification and storage of cholesterol in affected cells.
Atherosclerosis and cardiovascular disease
Selective inhibition of SOAT2 with BVD327 shows anti-atherogenic activity in apolipoprotein E knockout mice, a classic model of atherosclerosis. This links sterol O-acyltransferase activity to plaque formation and cardiovascular risk, and supports SOAT2 as a therapeutic target. Lipid-lowering drugs have also been discussed in the context of sterol metabolism.
Cancer immunity and aged regulatory T cells
Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity. This finding connects sterol O-acyltransferase activity to immunometabolism and suggests that modulating the enzyme could affect cancer immune surveillance.
Liver lipid droplet pathology
Sterol O-acyltransferase activity is required to form cholesterol crystals in hepatocyte lipid droplets. This process may contribute to liver lipid stress and has implications for fatty liver disease and related metabolic conditions.
From sterol O-acyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SOAT1 or SOAT2 loss affect cholesterol esterification? | CRISPR knockout of SOAT1 or SOAT2 in cell lines, followed by lipidomics [1,2] |
| Does a specific point mutation alter catalytic activity? | Point-mutation knock-in of SOAT1/2 catalytic residues |
| Can a tagged SOAT protein be used for localization studies? | Knock-in of fluorescent or epitope tags at the endogenous locus |
| Does overexpression of SOAT2 increase sterol ester storage? | Overexpression of SOAT2 in cultured cells or zebrafish [5,8] |
| Can selective inhibitors discriminate SOAT1 from SOAT2? | Pharmacological treatment of wild-type and knockout cells with BVD327 or terpendole congeners [3,4] |
| Does SOAT activity modify disease severity in NPC1? | NPC1 mutant cells or animal models with SOAT1 genetic modification |
How to Study the sterol O-acyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled acyl-CoA assay | Sterol O-acyltransferase enzymatic activity | Comparing SOAT1 vs SOAT2 activity and inhibitor testing [1,3] |
| LC-MS lipidomics | Sterol ester and free sterol levels | Quantifying esterification products in cells and tissues |
| Thin-layer chromatography | Separation of sterol esters from free sterols | Biochemical characterization of enzyme products |
| Fluorescence microscopy | Lipid droplet and cholesterol crystal formation | Hepatocyte lipid droplet studies |
| CRISPR knockout | Loss-of-function phenotype | Determining requirement for SOAT1 or SOAT2 [1,2] |
| CRISPR knock-in | Tagged or mutant SOAT expression | Localization and catalytic residue studies |
| Overexpression | Gain-of-function effects | Testing increased sterol ester storage [5,8] |
| Animal model phenotyping | Atherosclerosis or developmental outcomes | ApoE knockout mice and zebrafish embryos [4,5] |
Biochemical assays for sterol O-acyltransferase activity
Enzymatic activity can be measured using radiolabeled or fluorescent acyl-CoA substrates and sterol acceptors, followed by separation of sterol esters by thin-layer chromatography or liquid chromatography-mass spectrometry. Such assays are used to compare SOAT1 and SOAT2 activity and to test inhibitors like terpendole congeners and BVD327 [3,4].
Lipidomics and cholesterol crystal detection
Mass spectrometry-based lipidomics quantifies sterol esters and free sterols in cells and tissues. In hepatocytes, cholesterol crystal formation in lipid droplets can be assessed by imaging, as SOAT activity is required for this process.
Genetic manipulation and CRISPR screens
CRISPR knockout, point mutation, and knock-in models allow precise dissection of SOAT1 and SOAT2 functions [1,2]. Overexpression models can test gain-of-function effects, such as increased sterol ester storage or altered cholesterol trafficking [5,8].
Disease model phenotyping
Animal models such as ApoE knockout mice and zebrafish embryos are used to study atherosclerosis and developmental cholesterol trafficking, respectively [4,5]. In these models, SOAT activity can be modulated genetically or pharmacologically, and outcomes such as plaque size or yolk cholesterol distribution are measured [4,5].
How CRISPR Can Be Used to Study GO:0004772 sterol O-acyltransferase activity
Knockout
CRISPR knockout of SOAT1 or SOAT2 eliminates sterol O-acyltransferase activity, allowing researchers to test which isoform is responsible for specific phenotypes such as cholesterol crystal formation or sterol ester storage [1,2]. Knockout models are also useful for validating selective inhibitors, as the remaining activity can be attributed to the non-targeted isoform [3,4].
Point Mutation
Point mutations can be introduced into catalytic residues of SOAT1 or SOAT2 to dissect the enzymatic mechanism and to test whether specific amino acids are required for acyl transfer. Such models help distinguish loss of catalytic activity from loss of protein expression or localization.
Knock-in
Knock-in of fluorescent or epitope tags at the endogenous SOAT1 or SOAT2 locus enables real-time imaging and biochemical purification of the enzyme without overexpression artifacts. Tagged knock-in models are valuable for studying subcellular localization and interactions with lipid droplets.
Overexpression
Overexpression of SOAT1 or SOAT2 increases sterol esterification and can model conditions of enhanced lipid storage, such as those seen in aged regulatory T cells or during zebrafish embryogenesis [5,8]. Overexpression models are also used to test whether increased enzyme levels are sufficient to drive phenotypes like altered cholesterol trafficking [5,8].
How EDITGENE Supports sterol O-acyltransferase activity Research
Researchers studying sterol O-acyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, disease modification, or drug response. EDITGENE provides CRISPR-based cell models and screening services to support these investigations, from single-gene knockout to genome-wide library screens.
Contact EDITGENE today to design your custom CRISPR model for sterol O-acyltransferase activity research.
Frequently Asked Questions About sterol O-acyltransferase activity
What is sterol O-acyltransferase activity?
Sterol O-acyltransferase activity (GO:0004772) is the enzyme function that catalyzes the reaction: a long-chain fatty acyl-CoA + a sterol = a sterol ester + CoA.
What genes are involved in sterol O-acyltransferase activity?
The main genes are SOAT1 (ACAT1) and SOAT2 (ACAT2), which encode endoplasmic reticulum enzymes that esterify sterols [1,2].
What is the difference between SOAT1 and SOAT2?
SOAT1 is widely expressed and acts on various sterols, while SOAT2 has more restricted expression and contributes to specific processes such as yolk cholesterol trafficking and atherosclerosis [4,5].
How is sterol O-acyltransferase activity measured?
It can be measured using radiolabeled or fluorescent acyl-CoA substrates, followed by thin-layer chromatography or mass spectrometry to detect sterol esters.
What diseases are linked to sterol O-acyltransferase activity?
It has been linked to Niemann-Pick disease type C1, atherosclerosis, cholesterol crystal formation in hepatocytes, and reduced anti-tumor immunity in aged regulatory T cells [1,2,4,8].
Can sterol O-acyltransferase activity be inhibited?
Yes, natural products such as terpendole congeners and synthetic compounds like BVD327 inhibit the activity, with BVD327 showing selectivity for SOAT2 [3,4].
What is the role of SOAT2 in zebrafish?
SOAT2 contributes to yolk cholesterol trafficking during zebrafish embryogenesis.
How does SOAT activity affect lipid droplets?
SOAT activity produces sterol esters that are stored in lipid droplets and is required for cholesterol crystal formation in hepatocyte lipid droplets.
Is sterol O-acyltransferase activity conserved?
Yes, it is found in mammals and also in microorganisms such as thraustochytrids, where a DGAT2-like enzyme can be modified to increase sterol production.
What CRISPR models are available for studying SOAT genes?
Knockout, point-mutation, knock-in, and overexpression models can be generated for SOAT1 and SOAT2 to study their functions in lipid metabolism and disease [1,2,5,8].
Conclusion
Sterol O-acyltransferase activity (GO:0004772) is a fundamental enzymatic function that esterifies sterols using acyl-CoA, thereby controlling the balance between free sterols and stored sterol esters. Its two main mammalian enzymes, SOAT1 and SOAT2, have distinct roles in cholesterol crystal formation, Niemann-Pick disease type C1, atherosclerosis, and anti-tumor immunity [1,2,4,8]. Pharmacological inhibitors and CRISPR models provide powerful tools to dissect these roles and to explore therapeutic applications [3,4]. Continued research using precise genetic models and lipidomics will further clarify how this activity contributes to health and disease.
References
- 1. Bairos JA et al.. 2024. Sterol O-acyltransferase (SOAT/ACAT) activity is required to form cholesterol crystals in hepatocyte lipid droplets.. Biochim Biophys Acta Mol Cell Biol Lipids 1869(6):159512 PMID: 38761895
- 2. Farhat NY et al.. 2024. Sterol O-Acyltransferase 1 (SOAT1): A Genetic Modifier of Niemann-Pick Disease, Type C1.. Int J Mol Sci 25(8) PMID: 38673803
- 3. Nur EAA et al.. 2020. New Terpendole Congeners, Inhibitors of Sterol O-Acyltransferase, Produced by Volutella citrinella BF-0440.. Molecules 25(13) PMID: 32640743
- 4. Ohshiro T et al.. 2020. The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice.. Biol Pharm Bull 43(6):951-958 PMID: 32475917
- 5. Chang NY et al.. 2016. Sterol O-Acyltransferase 2 Contributes to the Yolk Cholesterol Trafficking during Zebrafish Embryogenesis.. PLoS One 11(12):e0167644 PMID: 27936201
- 6. Hirakawa Y et al.. 2001. [Lipid-lowering drugs].. Nihon Yakurigaku Zasshi 118(6):389-95 PMID: 11778457
- 7. Ishibashi Y et al.. 2023. Characterization of thraustochytrid-specific sterol O-acyltransferase: modification of DGAT2-like enzyme to increase the sterol production in Aurantiochytrium limacinum mh0186.. Appl Environ Microbiol 89(11):e0100123 PMID: 37874286
- 8. Zhang M et al.. 2025. Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced anti-tumor immunity.. Nat Commun 16(1):630 PMID: 39805872
